Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I'm attending NASDAQ: TLSA - Tiziana Life Sciences - Group Investor Call. Would you like to attend?
https://www.linkedin.com/events/nasdaq-tlsa-tizianalifesciences6848327389894766592
Can someone ask. Where the hell accustem is and why no communication or marketing.... its abysmal
What's happening with accustem? Please ask. Communication is abysmal
I'm sure someone will ask on a tiziana call about a separate /demerged company. Might as well ask them about the new mcflurry at mcdonalds.
The accustem paperwork will be out within the next 2 weeks for everyone to read.
The only problem I have with their Investors calls from previous is that there is later a separate discussion with Institutional Investors that private investors are locked out of .
Obviously Institutional investors have invested a lot more money than private investors that gives them access to more sensitive strategic information but at the same time these calls also attract new large investment .
There is so much potential here but as their pipelines are about to move on to the next stages they have to ensure they have the capital available to continue with further development.
IMO any important news that private investors gain access to, when ready will also be available through the normal news outlets so don't expect too much from these calls even though some of the frustration around is understandable based on the past updates.
Hopefully some good news will be made available soon.
If they refuse to discuss any aspect pf Accustem it shows them for what they are. Tiziana has done a capital reduction with Accustem assets so Accustem is still very much related to Tiziana.
On another note - quite nice to visit the TILS board and not see any RED.
Once this corporate reorg is done (agreed not been handled the best way) hopefully we can get back to the main business of helping to cure that b@stard cancer. ATB
DCR:
A statement from an RNS: Fri, 2nd Jul 2021 12:30 RNS Number : 0389E Accustem Sciences Limited 02 July 2021
'This will formally conclude the separation of Accustem from Tiziana Life Sciences plc and no further information concerning Accustem will be published on the Tiziana website. Regular updates will be posted to the Accustem website.'
As much as it grates on people/investors, this is TILS BoD's get out clause for any questions on Accustem.
BB
The Institucional shares proportion on Nasdaq is now 2.87 % ? down 3% since trading stopped on LSE! interesting
I'm not sure they can promote the free accustem shares pumping the tils price and profiting from it and simply walk away. Such action would be morally wrong and commercially damaging
I'd not be surprised at a class action and I'll join. The action to date is a disgrace as is the total lack of any communication
Has anyone here bothered to phone up TILS to ask questions about Accustem? Emails can be easily ignored, but phone calls can't be.
I'm attending NASDAQ: TLSA - Tiziana Life Sciences - Group Investor Call. Would you like to attend?
https://www.linkedin.com/events/nasdaq-tlsa-tizianalifesciences6848327389894766592
Anything interesting come up?